Shares of Healthpeak Properties, Inc. (NYSE:DOC – Get Free Report) have received a consensus recommendation of “Hold” from the eighteen analysts that are covering the firm, MarketBeat.com reports. Fourteen investment analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average twelve-month target price among analysts that have issued a report on the stock in the last year is $21.7188.
Several research firms recently weighed in on DOC. Wells Fargo & Company lifted their price target on Healthpeak Properties from $20.00 to $22.00 and gave the stock an “equal weight” rating in a report on Wednesday, July 15th. BMO Capital Markets upped their price objective on Healthpeak Properties from $20.00 to $24.00 and gave the company an “outperform” rating in a report on Monday, June 15th. Citigroup increased their price objective on Healthpeak Properties from $20.00 to $22.00 and gave the stock a “neutral” rating in a research report on Tuesday, August 11th. JPMorgan Chase & Co. boosted their target price on shares of Healthpeak Properties from $18.00 to $21.00 and gave the company a “neutral” rating in a research report on Wednesday, June 24th. Finally, Royal Bank Of Canada lifted their price objective on shares of Healthpeak Properties from $21.00 to $24.00 and gave the stock an “outperform” rating in a research note on Monday, August 10th.
Get Our Latest Stock Analysis on DOC
Hedge Funds Weigh In On Healthpeak Properties
Healthpeak Properties Stock Down 0.3%
DOC opened at $20.32 on Friday. The stock’s fifty day simple moving average is $21.42 and its 200 day simple moving average is $19.45. Healthpeak Properties has a 1-year low of $15.70 and a 1-year high of $22.95. The stock has a market cap of $14.01 billion, a PE ratio of 58.04, a price-to-earnings-growth ratio of 2.51 and a beta of 1.01. The company has a current ratio of 3.02, a quick ratio of 3.02 and a debt-to-equity ratio of 1.06.
Healthpeak Properties (NYSE:DOC – Get Free Report) last released its quarterly earnings data on Tuesday, August 4th. The real estate investment trust reported $0.08 EPS for the quarter, beating the consensus estimate of $0.03 by $0.05. The firm had revenue of $771.58 million for the quarter, compared to the consensus estimate of $725.64 million. Healthpeak Properties had a net margin of 8.24% and a return on equity of 2.79%. The company’s quarterly revenue was up 11.1% on a year-over-year basis. During the same period in the previous year, the company earned $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. As a group, research analysts expect that Healthpeak Properties will post 1.77 earnings per share for the current year.
Healthpeak Properties Dividend Announcement
The business also recently declared a monthly dividend, which will be paid on Friday, September 25th. Investors of record on Monday, September 14th will be paid a $0.1017 dividend. This represents a c) annualized dividend and a dividend yield of 6.0%. The ex-dividend date is Monday, September 14th. Healthpeak Properties’s payout ratio is 348.57%.
About Healthpeak Properties
Healthpeak Properties, Inc (NYSE:DOC) is a real estate investment trust that owns, develops, leases and manages healthcare-related properties in the United States. The company focuses primarily on outpatient medical buildings, which are leased to healthcare providers, physician groups and other medical users.
Healthpeak’s portfolio also includes life science and senior housing properties, although its business has increasingly centered on outpatient medical real estate. Its properties are generally located in established healthcare markets and are designed to support services such as physician offices, specialty care, diagnostics and ambulatory treatment.
The company was formerly known as HCP, Inc and adopted the Healthpeak Properties name in 2019.
Read More
- Five stocks we like better than Healthpeak Properties
- Block Makes a Federal Trust Bank Move That Could Reshape Its Fintech Model
- Kroger’s Textbook Entry for Buy-and-Hold Investors
- AST SpaceMobile Looks to Extend Its 30-Day FCC Satellite Testing Window
- Amgen Drops 10% on a Trial It Didn’t Even Run
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.
